SPONSOR

Seoul National University Hospital

Total Trials

Recruiting

Phases

Phase 2, Phase 4

Conditions studied: Atrial Fibrillation Chronic Obstructive Pulmonary Disease Asthma Idiopathic Pulmonary Fibrosis Nontuberculous Mycobacterium Infection Bronchiectasis Lung Cancer Hepatocellular Carcinoma (HCC)Radioembolization Intensive Care Unit Delirium

Seoul National University Hospital is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Asthma, Idiopathic Pulmonary Fibrosis.

The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Seoul National University Hospital

How many clinical trials has Seoul National University Hospital sponsored?

ClinicalMetric currently tracks 17 clinical trials sponsored by Seoul National University Hospital, of which 17 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Asthma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Seoul National University Hospital research focus on?

Seoul National University Hospital clinical trials span Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Asthma, Idiopathic Pulmonary Fibrosis, Nontuberculous Mycobacterium Infection, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Seoul National University Hospital clinical trial?

To participate in a Seoul National University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Seoul National University Hospital trials with current recruitment status updated daily.

Seoul National University Hospital

Frequently Asked Questions — Seoul National University Hospital

Clinical Trials by Seoul National University Hospital

SCAR Burden of Left Atrium Guided cathEter Ablation sTrategy for Persistent Atrial Fibrillation

Controls for Respiratory Diseases

Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

Streamlining Radioembolization for Small HCC

Prevention of Delirium in ICU Using Multimodal Interventions

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)

Stress Management with Real-time Bio-signal Biofeedback

Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data

Korean College of Rheumatology Biologics and Targeted Therapy Registry

Scout Dose of Resin Microspheres

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Intrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy

Nostril Side on Epistaxis

Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane

Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients

EOI Block in Otoplasty With Rib Cartilage Graft

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery